Found: 17
Select item for more details and to access through your institution.
1741. Invasive Fungal Infections in Patients with Multiple Myeloma in the Era of Novel Therapies.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S637, doi. 10.1093/ofid/ofz360.1604
- By:
- Publication type:
- Article
A phase IIb trial of vorinostat in combination with lenalidomide and dexamethasone in patients with multiple myeloma refractory to previous lenalidomide-containing regimens.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 3, p. 440, doi. 10.1111/bjh.14429
- By:
- Publication type:
- Article
Trial designs and endpoints for immune therapies in multiple myeloma.
- Published in:
- American Journal of Hematology, 2023, v. 98, p. S35, doi. 10.1002/ajh.26753
- By:
- Publication type:
- Article
Peripheral neuropathy symptoms, pain, and functioning in previously treated multiple myeloma patients treated with selinexor, bortezomib, and dexamethasone.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 10, p. E383, doi. 10.1002/ajh.26282
- By:
- Publication type:
- Article
Renal failure among multiple myeloma patients utilizing carfilzomib and associated factors in the "real world".
- Published in:
- Annals of Hematology, 2021, v. 100, n. 5, p. 1261, doi. 10.1007/s00277-021-04420-3
- By:
- Publication type:
- Article
B-cell maturation antigen (BCMA) in multiple myeloma: the new frontier of targeted therapies.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721989585
- By:
- Publication type:
- Article
Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myeloma.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620720987075
- By:
- Publication type:
- Article
The Safety and Efficacy of Radiation Therapy with Concurrent Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin-Based Systemic Therapy for Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 3, p. 192, doi. 10.1016/j.clml.2021.09.015
- By:
- Publication type:
- Article
P-063: Pathogenic germline variants in hereditary cancer genes in patients with Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S73, doi. 10.1016/S2152-2650(21)02197-2
- By:
- Publication type:
- Article
OAB-053: Clinical outcomes of relapsed/refractory multiple myeloma patients after BCMA-targeted CAR T therapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S38, doi. 10.1016/S2152-2650(21)02133-9
- By:
- Publication type:
- Article
Prevalence and Survival Impact of Self-Reported Symptom and Psychological Distress Among Patients With Multiple Myeloma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A phase 1/2 study to assess safety and dose of ixazomib in combination with cyclophosphamide and dexamethasone in newly diagnosed patients with light chain (AL) amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e330, doi. 10.1016/j.clml.2019.09.543
- By:
- Publication type:
- Article
Gastric adenocarcinoma: clinicopathologic differences among Hispanics and non-Hispanic whites. A single Institution's experience over 14 years.
- Published in:
- Annals of Gastroenterology, 2016, v. 29, n. 3, p. 325, doi. 10.20524/aog.2016.0030
- By:
- Publication type:
- Article
Outcome of patients with relapsed or refractory anaplastic large cell lymphoma who have failed brentuximab vedotin.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Recapturing disease response: A phase 2 study of carfilzomib 56 mg/m<sup>2</sup> in patients with relapsed or refractory multiple myeloma who have progressed on carfilzomib 27 mg/m<sup>2</sup>.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 2, p. E51, doi. 10.1002/ajh.25695
- By:
- Publication type:
- Article
Elotuzumab for the treatment of multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0284-z
- By:
- Publication type:
- Article
Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0283-0
- By:
- Publication type:
- Article